Cell therapies are powerful treatments that harness immune cells to fight cancer within the body. The expertise and skill of our cell therapy treatment teams at NewYork-Presbyterian/Columbia University Irving Medical Center and NewYork-Presbyterian/Weill Cornell Cancer Center — coupled with top specialists from all areas of medicine within our network — make NewYork-Presbyterian the ideal place in New York City to receive these potentially lifesaving treatments. Our world-class providers offer:
- Chimeric antigen receptor T-cell therapy, or CAR T-cell therapy, which is used to treat pediatric and adult patients with blood cancers that came back or keep growing despite chemotherapy. Multiple CAR T-cell therapies have been approved by the FDA.
- The tumor-infiltrating lymphocyte (TIL) therapy includes lifileucel, which is FDA-approved for inoperable or metastatic melanoma that keeps growing after other immunotherapies.
- The T-cell receptor (TCR) therapy, which gives T-cells the ability to find and fight proteins hidden inside tumor cells, where most cancer-specific proteins are found.